Review Article
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma
Table 3
Oroxylin A in HCC with possible mechanisms discussed in this paper.
| Subfamily | Flavonoids | Typical origin | In vitro/in vivo Cell lines/modes Effective dose | Effects and related mechanisms | Author (year) References |
| Flavones | Oroxylin A | Scutellaria baicalensis Georgi | In vitro HepG2 25–100 M | ↑ H2O2-triggered overactivation of the UPR pathway and ↓ AKT signaling |
Xu et al. (2012) [23] |
| | | | In vitro/in vivo HepG2 cells/BALB/c nude mice 80 M/40 mg/kg; 80 mg/kg | ↑ autophagy-mediated antitumor activity ↓ PI3K-PTEN-Akt-mTOR signaling pathway | Zou et al. (2012) [24] |
| | | | In vitro HepG2 cells 50, 100 and 200 M | ↓ CAM-DR, ↓ integrin1 | Zhu et al. (2012) [80] |
| | | | In vitro/in vivo HepG2 cells/transplanted H22 mice 50 M/1,000 mg (kg/day) | ↑ sensitivity of HepG2 cells to 5-FU by ↑ P53 and cleaved PARP; ↓ COX-2, ↓ Bcl-2, and ↓ pro-caspase-3 | Zhao et al. (2010) [79] |
| | | | In vitro HepG2 cells 50, 100, and 200 M | ↑ apoptosis by MAC-related mitochondrial pathway | Liu et al. (2009) [40] |
| | | | In vitro HepG2 50, 100, and 150 M | ↑ apoptotic and G(2)/M phase arrest cells ↑ programmed cell death via ↓ Bcl-2 protein, ↓ pro-caspase-3 protein, and ↑ Bax protein | Hu et al. (2006) [97] |
|
|
For abbreviations see footer of Table 1.
|